Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$3.81B
-6.9% from 2023
Prescriptions
4.0M
$945.51 per claim
Patients
828K
231,789 prescribers
Total spending, 2024
$3.81B
$4,597.26 per patient
Medicare prescription drug plans paid $3.81B for Januvia in 2024, for 4,025,920 prescriptions and refills to 827,991 patients (down 6.9% from 2023). The average cost per claim was $945.51.
California had the highest Medicare cost for Januvia in 2024: $434.3M for 461,907 claims, followed by New York ($389.8M).
Bin Wang, internal medicine in Flushing, NY, had the highest Medicare cost for Januvia in 2024: 1,165 claims costing $886K.
Januvia is made by Merck & Co., Inc. (MRK), listed in the Medicare spending data as Merck Sharp & D.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Bin Wang Flushing, NY | Internal Medicine | 1,165 | 164 | $886K |
| Kelvin Mai Santa Ana, CA | Internal Medicine | 946 | 160 | $739K |
| Rodolfo Guzman Bronx, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 231,037 | 4,241,351 | 884,560 | $4.10B |
| 2023 | 230,818 | 4,027,265 | 842,948 | $4.09B |
| 2024 | 231,789 | 4,025,920 | 827,991 | $3.81B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 649 |
| 150 |
| $706K |
| Hossam H Amin Brooklyn, NY | Pulmonary Disease | 940 | 131 | $676K |
| Xiangsheng Zheng Birmingham, AL | Internal Medicine | 1,101 | 138 | $634K |
| Stella Ilyayeva Rego Park, NY | Internal Medicine | 877 | 165 | $626K |
| Jose L Vega III Yuma, AZ | Family Practice | 461 | 142 | $550K |
| Sonwoo Lee Los Angeles, CA | Internal Medicine | 818 | 98 | $531K |
| Saleh Khaddash Clifton, NJ | Endocrinology | 537 | 135 | $521K |
| Jose R Baez Lawrence, MA | Internal Medicine | 825 | 150 | $509K |
| Pankaj Shukla Bakersfield, CA | Internal Medicine | 618 | 115 | $504K |
| Mauricio E Jimenez El Paso, TX | Internal Medicine | 350 | 111 | $495K |
| Ajay G Meka Santa Ana, CA | Internal Medicine | 441 | 130 | $474K |
| Eugenio Angueira-Serrano Miami, FL | Endocrinology | 675 | 151 | $468K |
| Paul H Deutsch Norwich, CT | Internal Medicine | 366 | 89 | $468K |
| Benito A Marranzini El Paso, TX | Endocrinology | 359 | 124 | $467K |
| Jason S Paek Rowland Heights, CA | Internal Medicine | 646 | 103 | $463K |
| Pankaj V Patel Edison, NJ | Internal Medicine | 450 | 98 | $457K |
| Stanley Kim Edison, NJ | Nephrology | 566 | 85 | $453K |
| Jaime F Lopez-Santini New York, NY | Internal Medicine | 372 | 94 | $448K |
| Paramjit S Takhar Sacramento, CA | Family Practice | 411 | 108 | $446K |
| Sixto R Caro Brooklyn, NY | Internal Medicine | 511 | 94 | $441K |
| Muhammad Bakleh Flint, MI | Endocrinology | 440 | 112 | $433K |
| Mohammad A Chaudhry Union City, NJ | Internal Medicine | 419 | 87 | $432K |
| Yong S Lin New York, NY | Internal Medicine | 526 | 77 | $429K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Merck Sharp & D MRK | 4,027,317 | $3.81B |